Tacrolimus (FK506) is superior to cyclosporine in liver transplantation
- 1 February 1997
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 534-538
- https://doi.org/10.1016/s0041-1345(96)00630-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Hepatitis C Viral Infection in Liver TransplantationArchives of Surgery, 1996
- THE RELATIVE EFFECTS OF FK506 AND CYCLOSPORINE ON SHORT- AND LONG-TERM KIDNEY GRAFT SURVIVAL1,2,3Transplantation, 1995
- Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantationHepatology, 1995
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- The Mechanism of Action of FK‐506 and Cyclosporin AAnnals of the New York Academy of Sciences, 1993
- FK506Transplantation, 1992
- The mechanism of action of the immunosuppressive drug FK-506Cellular Immunology, 1989